Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus
Authors
Keywords
-
Journal
ARTHRITIS CARE & RESEARCH
Volume 64, Issue 9, Pages 1373-1381
Publisher
Wiley
Online
2012-04-18
DOI
10.1002/acr.21704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Ro52 monoclonal antibodies specific for amino acid 200–239, but not other Ro52 epitopes, induce congenital heart block in a rat model
- (2011) Aurélie Ambrosi et al. ANNALS OF THE RHEUMATIC DISEASES
- Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus
- (2011) Peter M. Izmirly et al. CIRCULATION
- 2-Glycoprotein I and Protection from Anti-SSA/Ro60-Associated Cardiac Manifestations of Neonatal Lupus
- (2011) J. H. Reed et al. JOURNAL OF IMMUNOLOGY
- Prolongation of the Atrioventricular Conduction in Fetuses Exposed to Maternal Anti-Ro/SSA and Anti-La/SSB Antibodies Did Not Predict Progressive Heart Block
- (2011) Edgar T. Jaeggi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Population-based Investigation of the Autoantibody Profile in Mothers of Children with Atrioventricular Block
- (2011) S. Salomonsson et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial
- (2010) Deborah M. Friedman et al. ARTHRITIS AND RHEUMATISM
- Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus
- (2010) Robert M. Clancy et al. ARTHRITIS AND RHEUMATISM
- Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera
- (2010) V. RICCHIUTI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Ro60-Associated Single-Stranded RNA Links Inflammation with Fetal Cardiac Fibrosis via Ligation of TLRs: A Novel Pathway to Autoimmune-Associated Heart Block
- (2010) Robert M. Clancy et al. JOURNAL OF IMMUNOLOGY
- The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus
- (2010) Edgar Jaeggi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- When the leveedoesn'tbreak: A novel role of β2-glycoprotein I to protect against congenital heart block
- (2009) Robert M. Clancy ARTHRITIS AND RHEUMATISM
- Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors
- (2009) Carolina Llanos et al. ARTHRITIS AND RHEUMATISM
- Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies
- (2009) Antonio Brucato et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Congenital heart block: Identification of autoantibody binding site on the extracellular loop (domain I, S5–S6) of α1D L-type Ca channel
- (2009) Eddy Karnabi et al. JOURNAL OF AUTOIMMUNITY
- A B cell apotope of Ro 60 in systemic lupus erythematosus
- (2008) Joanne H. Reed et al. ARTHRITIS AND RHEUMATISM
- Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block
- (2008) Deborah M. Friedman et al. CIRCULATION
- Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block
- (2008) L. Strandberg et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block
- (2008) J.P. Buyon et al. LUPUS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started